Waksal Harlan 4
4 · Lyra Therapeutics, Inc. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Waksal Harlan
DirectorExecutive Chair
Transactions
- Award
Performance-based Restricted Stock Units
2024-12-09−128,333→ 0 total→ Common Stock (128,333 underlying)
Footnotes (2)
- [F1]Each Performance-based Restricted Stock unit ("PSU") represented a contingent right to receive one share of the Issuer's common stock.
- [F2]On March 21, 2024, the Reporting Person was granted a PSU for an aggregate of up to 385,000 shares of common stock under the Issuer's 2020 Incentive Award Plan (the "Agreement"). Under the terms of the Agreement, the underlying PSUs will become earned upon certain milestone events. On December 9, 2024, the Issuer determined that Milestone 1 of the PSU was achieved, resulting in 128,333 PSUs being earned. The earned PSUs will vest on January 31, 2028. The PSUs have no expiration date.